Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation

NCT05679024 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT05679024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05679024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Lead sponsor
Region Stockholm
Phase
Phase 3
Overall status
Recruiting
Start date
February 17, 2023
Completion date
December 31, 2028
Enrollment
1,400 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiovascular complication, chronic kidney diseases, death, intracerebral hemorrhage, kidney transplant; complications, major bleed, stroke, thromboses, venous